ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
finneces
|
5.5K |
2.7M |
7 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
5.5K
|
2.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
finneces
|
5.5K |
2.7M |
2 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
5.5K
|
2.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Institutional Allocation
|
|
finneces
|
263 |
70K |
17 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
263
|
70K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CEO Presentation to 2023 Annual General Meeting
|
|
finneces
|
114 |
37K |
5 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
114
|
37K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Attending AGM?
|
|
finneces
|
71 |
18K |
1 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
71
|
18K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Attending AGM?
|
|
finneces
|
71 |
18K |
2 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
71
|
18K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Attending AGM?
|
|
finneces
|
71 |
18K |
2 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
71
|
18K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
finneces
|
574 |
199K |
3 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
199K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
finneces
|
574 |
199K |
9 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
199K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Type A Meeting
|
|
finneces
|
5 |
2.8K |
13 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
5
|
2.8K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
finneces
|
1.3K |
557K |
26 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.3K
|
557K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
finneces
|
1.3K |
557K |
2 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
557K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
How will you celebrate when FDA gives the Tick
|
|
finneces
|
82 |
38K |
8 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
82
|
38K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
finneces
|
17K |
6.8M |
24 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
17K
|
6.8M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
finneces
|
17K |
6.8M |
18 |
29/07/23 |
29/07/23 |
ASX - By Stock
|
17K
|
6.8M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Director Appointed to Strategic Advisory Role
|
|
finneces
|
106 |
44K |
8 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
106
|
44K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
fda approval
|
|
finneces
|
25 |
14K |
53 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
25
|
14K
|
53
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
finneces
|
3.4K |
1.2M |
28 |
29/04/23 |
29/04/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
finneces
|
274 |
122K |
14 |
25/04/23 |
25/04/23 |
ASX - By Stock
|
274
|
122K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
finneces
|
3.4K |
1.2M |
18 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
18
|
|
ASX - By Stock
|
AHX |
Re:
Ann: H1 FY23 Results Release
|
|
finneces
|
6 |
4.3K |
1 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
6
|
4.3K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Who is getting a little bit excited?
|
|
finneces
|
18 |
5.3K |
5 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
18
|
5.3K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Prospectus for Warrants Related to Oaktree Facility
|
|
finneces
|
14 |
8.5K |
30 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
14
|
8.5K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
finneces
|
914 |
293K |
4 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
914
|
293K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
finneces
|
914 |
293K |
11 |
26/02/23 |
26/02/23 |
ASX - By Stock
|
914
|
293K
|
11
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
finneces
|
400 |
153K |
15 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
400
|
153K
|
15
|
|
Charts
|
MSB |
Re:
MSB - Chart
|
|
finneces
|
248 |
106K |
2 |
03/02/23 |
03/02/23 |
Charts
|
248
|
106K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
finneces
|
618 |
240K |
7 |
15/01/23 |
15/01/23 |
ASX - By Stock
|
618
|
240K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
finneces
|
618 |
240K |
6 |
02/01/23 |
02/01/23 |
ASX - By Stock
|
618
|
240K
|
6
|
|
Charts
|
MSB |
Re:
MSB - Chart
|
|
finneces
|
248 |
106K |
7 |
16/12/22 |
16/12/22 |
Charts
|
248
|
106K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB AGM - confidence restored
|
|
finneces
|
304 |
92K |
3 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
304
|
92K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB AGM - confidence restored
|
|
finneces
|
304 |
92K |
0 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
304
|
92K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB AGM - confidence restored
|
|
finneces
|
304 |
92K |
9 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
304
|
92K
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB AGM - confidence restored
|
|
finneces
|
304 |
92K |
7 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
304
|
92K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast First Quarter Financial Results Webcast
|
|
finneces
|
94 |
30K |
6 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
94
|
30K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast First Quarter Financial Results Webcast
|
|
finneces
|
94 |
30K |
12 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
94
|
30K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
finneces
|
17K |
6.8M |
4 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
17K
|
6.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
RWE for 2nd MSB COVID-19 ARDS P3 Trial
|
|
finneces
|
905 |
291K |
3 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
905
|
291K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
finneces
|
778 |
283K |
7 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
778
|
283K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
finneces
|
1.5K |
507K |
1 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
1.5K
|
507K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
finneces
|
1.5K |
507K |
2 |
06/11/22 |
06/11/22 |
ASX - By Stock
|
1.5K
|
507K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
finneces
|
1.5K |
507K |
4 |
06/11/22 |
06/11/22 |
ASX - By Stock
|
1.5K
|
507K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
finneces
|
576 |
206K |
11 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
576
|
206K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
finneces
|
576 |
206K |
2 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
576
|
206K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
finneces
|
576 |
206K |
31 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
576
|
206K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice
|
|
finneces
|
5 |
3.6K |
7 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
5
|
3.6K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
finneces
|
10K |
3.1M |
6 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
10K
|
3.1M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
finneces
|
10K |
3.1M |
7 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
10K
|
3.1M
|
7
|
|
ASX - By Stock
|
TEK |
Re:
Ann: Change of Director's Interest Notice - A Waislitz
|
|
finneces
|
18 |
7.2K |
3 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
18
|
7.2K
|
3
|
|
ASX - By Stock
|
TEK |
Re:
Ann: Change of Director's Interest Notice - A Waislitz
|
|
finneces
|
18 |
7.2K |
0 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
18
|
7.2K
|
0
|
|